HilleVax News and Activities

HilleVax is a company listed under the stock ticker HLVX (US).

Acquisition, funding and merger involving HilleVax.

• Xoma Royalty has announced the acquisition of HilleVax  (posted on August 5 2025).

View the org chart displaying its 15 main executives

Most searched biographies at HilleVax

• Rob Hershberg, Director, President and Chief Executive Officer
• Gary Dubin, Director
• Jaime Sepulveda, Director

Create your alert
to follow the executive moves at HilleVax.

HilleVax has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 15 2026).
• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by HilleVax

• HilleVax Announces Results from 5-Year Clinical Study Supporting Long-Term Immunogenicity of HIL-214 Norovirus Vaccine Candidate | HilleVax, Inc.
• HilleVax Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress | HilleVax, Inc.
• News | HilleVax, Inc.

Social media about HilleVax

• HilleVax on Wikipedia, Google News & Yahoo Finance
• HilleVax on LinkedIn, X (Twitter) & YouTube